Advertisement

Topics

Cancer Research UK appoints Professor Charles Swanton as its chief clinician

21:15 EDT 20 Jun 2017 | Cancer Research UK

Press release

Professor Charles Swanton

Cancer Research UK is pleased to announce the appointment of Professor Charles Swanton as its new chief clinician.

"I am delighted that Charles is joining the board as our new chief clinician. His work at the Crick on the TRACERx study involves analysing details of how lung cancers evolve over time, from diagnosis and throughout treatment, potentially up to death." - Sir Harpal Kumar, Cancer Research UK

Prof Swanton, who will also join the charity’s executive board later this summer, has enjoyed a long association with Cancer Research UK. He now leads a team at the Francis Crick Institute in London, working on an internationally acclaimed clinical study, TRACERx, analysing how lung cancer develops.

Prof Swanton became a Fellow of the Royal College of Physicians in 2002 and in 2008 went on to establish his own laboratory at Cancer Research UK’s London Research Institute. He is Professor of Personalised Cancer Medicine at University College London (UCL) and practises as a medical oncologist seeing patients at UCLH where he specialises in the treatment of lung cancers.

He is also one of the founding scientists of Achilles Therapeutics, which is seeking to develop a new immunotherapeutic approach to treating cancer. Last week he was elected as a member of the prestigious European Molecular Biology Organisation (EMBO), one of many prizes and awards he has now received for his ground-breaking work.

Professor Swanton succeeds Professor Peter Johnson who has been the charity’s chief clinician since 2008. Prof Johnson will continue to work closely with Cancer Research UK, undertaking his own research in immunotherapy at the University of Southampton, and playing a leading role in developing cancer research networks for the Francis Crick Institute.

Sir Harpal Kumar, Cancer Research UK’s chief executive, said: “I am delighted that Charles is joining the board as our new chief clinician. His work at the Crick on the TRACERx study involves analysing details of how lung cancers evolve over time, from diagnosis and throughout treatment, potentially up to death. The results are transforming our understanding of lung cancer and how we treat the disease.

“I would also like to pay tribute to Peter Johnson and to thank him for his hard work and immense contribution to Cancer Research UK for the last nine years. I am very pleased that he will remain closely involved with the charity in the future.”

Read more

Original Article: Cancer Research UK appoints Professor Charles Swanton as its chief clinician

NEXT ARTICLE

More From BioPortfolio on "Cancer Research UK appoints Professor Charles Swanton as its chief clinician"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...